ArticleInvestigational new drugs2024

Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.

Seyda Gungordu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.